Dr. Petter is the founding CEO and current CSO of Arrakis Therapeutics. Previously, Russ was Vice President of Drug Discovery at Avila Therapeutics and, upon the acquisition of Avila by Celgene in 2012, he became Celgene’s Vice President of Chemistry, a position he held until leaving to found Arrakis in 2015. Prior to Avila, Russ served as Vice President of Research at Mersana Therapeutics, Director of Small Molecule Drug Discovery at Biogen and as Section Head in Oncology Chemistry at Sandoz/Novartis. Prior to his career in industry, Russ was an Assistant Professor of Chemistry at the University of Pittsburgh. Russ holds an A.B. in chemistry from Dartmouth College and earned his PhD in organic chemistry at Duke University with Ned Porter. He was a post-doctoral fellow in Ron Breslow’s group at Columbia University.